| Von Willebrand factor for outcome prediction within different clinical stages of advanced chronic liver disease N Dominik, B Scheiner, A Zanetto, L Balcar, G Semmler, E Campello, ... Alimentary Pharmacology & Therapeutics 59 (11), 1376-1386, 2024 | 7 | 2024 |
| The deep abdominal ultrasound transducer (DAX) increases the success rate and diagnostic accuracy of shear wave elastography for liver fibrosis assessment in patients with … DJM Bauer, L Nixdorf, N Dominik, M Schwarz, BS Hofer, L Hartl, ... Alimentary Pharmacology & Therapeutics, 2024 | 4 | 2024 |
| Insulin‐like growth factor‐1 in cirrhosis is linked to hepatic dysfunction and fibrogenesis and predicts liver‐related mortality L Hartl, M Schwarz, B Simbrunner, M Jachs, P Wolf, DJM Bauer, ... Alimentary pharmacology & therapeutics 61 (1), 88-98, 2025 | 3 | 2025 |
| Rapid improvement of hepatic steatosis and liver stiffness after metabolic/bariatric surgery: a prospective study L Nixdorf, L Hartl, S Ströhl, DM Felsenreich, M Mairinger, J Jedamzik, ... Scientific Reports 14 (1), 17558, 2024 | 3 | 2024 |
| Prevalence and prognostic value of zinc and selenium deficiency in advanced chronic liver disease N Dominik, L Balcar, G Semmler, B Simbrunner, M Schwarz, BS Hofer, ... Alimentary Pharmacology & Therapeutics 60 (7), 876-887, 2024 | 2 | 2024 |
| Reflex testing for anti-HDV in HBsAg-positive patients offers high diagnostic yield in a large Central European tertiary care center J Bernhard, M Schwarz, L Balcar, B Hofer, N Dominik, R Strassl, S Aberle, ... Scientific Reports 14 (1), 25921, 2024 | 1 | 2024 |
| Elevated Hepatic Copper Content in Porto‐Sinusoidal Vascular Disorder (PSVD): Leading Down a Wrong Track L Balcar, N Dominik, B Mozayani, G Semmler, E Halilbasic, M Mandorfer, ... Liver International 45 (2), e16175, 2025 | | 2025 |
| Minimal residual ascites three months after TIPS implantation indicates worse clinical outcome in patients with liver cirrhosis JB Mauz, L Hartl, A Kornfehl, SL Schütte, P Hemetsberger, ... JHEP Reports, 101335, 2025 | | 2025 |
| The Prognostic Role of IGF‐1 in Chronic Liver Disease—Authors' Reply L Hartl, M Schwarz, B Simbrunner, M Jachs, P Wolf, DJM Bauer, ... Alimentary Pharmacology & Therapeutics 61 (1), 228-229, 2025 | | 2025 |
| Decreasing interleukin-6 levels after TIPS predict outcomes in decompensated cirrhosis A Kornfehl, A Tiede, P Hemetsberger, J Kappel, T Müllner-Bucsics, ... JHEP Reports, 101308, 2024 | | 2024 |
| Zinc and Selenium-Potential Biomarkers for Chronic Liver Disease? Authors' Reply N Dominik, L Balcar, G Semmler, B Simbrunner, M Schwarz, BS Hofer, ... Alimentary pharmacology & therapeutics 60 (10), 1497-1498, 2024 | | 2024 |
| Helicobacter pylori and metabolic syndrome‐related von Willebrand factor and plasminogen activator inhibitor‐1 activity levels for outcome prediction of advanced chronic liver … B Scheiner, N Dominik, M Mandorfer Alimentary Pharmacology & Therapeutics 60 (4), 542-543, 2024 | | 2024 |
| WED-190 Elevated hepatic copper content in porto-sinusoidal-vascular disorder: leading down a wrong track L Balcar, N Dominik, B Mozayani, G Semmler, M Schwarz, E Halilbasic, ... Journal of Hepatology 80, S725, 2024 | | 2024 |
| SAT-122 Biomarkers of extracellular matrix remodelling are linked to portal hypertension and disease progression in patients with stable advanced chronic liver disease B Simbrunner, IF Villesen, L Balcar, G Semmler, L Hartl, B Hofer, M Jachs, ... Journal of Hepatology 80, S255, 2024 | | 2024 |
| SAT-105 Neutrophil extracellular traps are not linked to the development of decompensation, ACLF, or death in clinically stable patients with advanced chronic liver disease L Balcar, B Scheiner, B Simbrunner, M Jachs, L Hartl, G Semmler, B Hofer, ... Journal of Hepatology 80, S250, 2024 | | 2024 |
| SAT-111 Lower levels of Insulin-like growth factor 1 are independently associated with unfavorable prognosis in patients with advanced chronic liver disease L Hartl, M Schwarz, B Simbrunner, M Jachs, P Wolf, D Bauer, B Scheiner, ... Journal of Hepatology 80, S251, 2024 | | 2024 |
| THU-075-YI Incidence and prognostic value of zinc and seleniumdeficiency in cirrhosis N Dominik, L Balcar, G Semmler, B Simbrunner, M Schwarz, B Hofer, ... Journal of Hepatology 80, S166, 2024 | | 2024 |
| SAT-086-YI Assessment of portal hypertension risk by liver and spleen stiffness using real-time 2D-shear wave elastography-the prospective AiXplore study D Bauer, M Jachs, L Hartl, M Schwarz, L Balcar, B Hofer, N Dominik, ... Journal of Hepatology 80, S243-S244, 2024 | | 2024 |
| WED-171 Spleen stiffness and VWF-based non-invasive tests reflect severity of prehepatic and presinusoidal portal hypertension L Balcar, G Semmler, M Schwarz, N Dominik, B Hofer, K Stopfer, ... Journal of Hepatology 80, S717, 2024 | | 2024 |
| SAT-128 Circulating fibronectin levels are linked to endothelial dysfunction, fibrogenesis, and portal hypertension in advanced chronic liver disease B Simbrunner, L Balcar, F Hammer, B Hofer, G Semmler, M Jachs, L Hartl, ... Journal of Hepatology 80, S257, 2024 | | 2024 |
